RE:ValueSam, Pharmacyclics was bought by AbbVie last Friday for $21B. They replaced the Board in Sept 2008, then the President in Feb 2009, entered a partnership with J&J in Dec 2011, got their first year of revenue in 2014, and sold in early 2015. The share price in 2008 when they replaced the Board was so close to zero it is a line along the bottom of the graph. They sold the company for $261/share.